GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Dividend Yield %

ME Therapeutics Holding (XCNQ:METX) Dividend Yield % : 0.00% (As of Jun. 03, 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Dividend Yield %?

As of today (2024-06-03), the Trailing Annual Dividend Yield of ME Therapeutics Holding is 0.00%.

The historical rank and industry rank for ME Therapeutics Holding's Dividend Yield % or its related term are showing as below:

XCNQ:METX's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.56
* Ranked among companies with meaningful Dividend Yield % only.

ME Therapeutics Holding's Dividend Payout Ratio for the three months ended in Feb. 2024 was 0.00.

As of today (2024-06-03), the Forward Dividend Yield % of ME Therapeutics Holding is 0.00%.

ME Therapeutics Holding's Dividends per Share for the three months ended in Feb. 2024 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


ME Therapeutics Holding Dividend Yield % Historical Data

The historical data trend for ME Therapeutics Holding's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Dividend Yield % Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Dividend Yield %
- -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Dividend Yield % Get a 7-Day Free Trial - - - - -

Competitive Comparison of ME Therapeutics Holding's Dividend Yield %

For the Biotechnology subindustry, ME Therapeutics Holding's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ME Therapeutics Holding's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's Dividend Yield % falls into.



ME Therapeutics Holding Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


ME Therapeutics Holding  (XCNQ:METX) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


ME Therapeutics Holding Dividend Yield % Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


ME Therapeutics Holding (XCNQ:METX) Business Description

Comparable Companies
Traded in Other Exchanges
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines